Department Of Cardiology, Şişli International Kolan Hospital; Istanbul-Turkey.
Department of Cardiology, Faculty of Medicine, Ege University; İzmir-Turkey.
Anatol J Cardiol. 2021 May;25(5):294-303. doi: 10.5152/AnatolJCardiol.2021.39797.
In this study, we aimed to analyze the TURKMI registry to identify the factors associated with delays from symptom onset to treatment that would be the focus of improvement efforts in patients with acute myocardial infarction (AMI) in Turkey.
The TURKMI study is a nation-wide registry that was conducted in 50 centers capable of 24/7 primary percutaneous coronary intervention (PCI). All consecutive patients (n=1930) with AMI admitted to coronary care units within 48 hours of symptom onset were prospectively enrolled during a predefined 2-week period between November 1, 2018, and November 16, 2018. All the patients were examined in detail with regard to the time elapsed at each step from symptom onset to initiation of treatment, including door-to-balloon time (D2B) and total ischemic time (TIT).
After excluding patients who suffered an AMI within the hospital (2.6%), the analysis was conducted for 1879 patients. Most of the patients (49.5%) arrived by self-transport, 11.8% by emergency medical service (EMS) ambulance, and 38.6% were transferred from another EMS without PCI capability. The median time delay from symptom-onset to EMS call was 52.5 (15-180) min and from EMS call to EMS arrival 15 (10-20) min. In ST-segment elevation myocardial infarction (STEMI), the median D2B time was 36.5 (25-63) min, and median TIT was 195 (115-330) min. TIT was significantly prolonged from 151 (90-285) min to 250 (165-372) min in patients transferred from non-PCI centers. The major significant factors associated with time delay were patient-related delay and the mode of hospital arrival, both in STEMI and non-STEMI.
The baseline evaluation of the TURKMI study revealed that an important proportion of patients presenting with AMI within 48 hours of symptom onset reach the PCI treatment center later than the time proposed in the guidelines, and the use of EMS for admission to hospital is extremely low in Turkey. Patient-related factors and the mode of hospital admission were the major factors associated with the time delay to treatment.
本研究旨在分析 TURKMI 注册研究,以确定与从症状发作到治疗的延迟相关的因素,这些因素是改善土耳其急性心肌梗死(AMI)患者治疗效果的重点。
TURKMI 研究是一项全国性注册研究,在 50 家能够进行 24/7 经皮冠状动脉介入治疗(PCI)的中心进行。所有在症状发作后 48 小时内被收入冠心病监护病房的连续 AMI 患者(n=1930),在 2018 年 11 月 1 日至 16 日期间的两周预定时间段内前瞻性纳入研究。所有患者均详细检查从症状发作到开始治疗的每个步骤所经历的时间,包括门球时间(D2B)和总缺血时间(TIT)。
排除在医院发生 AMI 的患者(2.6%)后,对 1879 例患者进行了分析。大多数患者(49.5%)自行就诊,11.8%由紧急医疗服务(EMS)救护车转运,38.6%由无 PCI 能力的其他 EMS 转运而来。从症状发作到 EMS 呼叫的中位时间延迟为 52.5(15-180)分钟,从 EMS 呼叫到 EMS 到达的中位时间延迟为 15(10-20)分钟。在 ST 段抬高型心肌梗死(STEMI)中,D2B 时间的中位数为 36.5(25-63)分钟,TIT 的中位数为 195(115-330)分钟。与来自非 PCI 中心的患者相比,TIT 明显延长,从 151(90-285)分钟延长至 250(165-372)分钟。STEMI 和非 STEMI 患者中,与时间延迟相关的主要显著因素是患者相关的延迟和入院方式。
TURKMI 研究的基线评估显示,在症状发作后 48 小时内就诊的 AMI 患者中,相当一部分患者到达 PCI 治疗中心的时间晚于指南建议的时间,土耳其 EMS 入院率极低。与治疗时间延迟相关的主要因素是患者相关因素和入院方式。